Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03288220 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Influence of Brain Oscillation-Dependent TMS on Motor Function

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Mar 31, 2029 → Mar 30, 2030
See other at-risk trials from National Institute of Neurological Disorders and Stroke (NINDS)

Record History

The 50 most recent of 373 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Re-verified, no change to tracked fields
  3. Primary and study completion pushed from Mar 31, 2029 to Mar 30, 2030 Eligibility criteria expanded, about 34 words Show 1 more changeShow less
    • Eligibility criteria expanded, about 34 words
  4. 4 versions Re-verified since Apr 17, 2026, no change to tracked fieldsv367-v370
  5. Primary and study completion dates: Mar 31, 2026 to Mar 31, 2029v366
Show 42 earlier versionsHide 42 earlier versions
  1. 4 versions Re-verified since Sep 25, 2025, no change to tracked fieldsv362-v365
  2. Primary and study completion dates: Mar 31, 2025 to Mar 31, 2026v361
  3. 8 versions Re-verified since May 3, 2024, no change to tracked fieldsv353-v360
  4. Primary and study completion dates: Mar 31, 2024 to Mar 31, 2025v352
  5. 2 versions Re-verified since Jan 11, 2024, no change to tracked fieldsv350-v351
  6. Eligibility criteria expanded, about 35 words Study description shortened, about 156 wordsv349 Show 1 more changeShow less
    • Study description shortened, about 156 words

    See this version in full on ClinicalTrials.gov ↗

  7. Enrollment target: 52 to 114v348
  8. 3 versions Re-verified since Sep 15, 2023, no change to tracked fieldsv345-v347
  9. Study Status, Study Description, Eligibilityv344
  10. Re-verified, no change to tracked fieldsv343
  11. Primary and study completion dates: Mar 31, 2023 to Mar 31, 2024v342
  12. 18 versions Re-verified since Jun 14, 2022, no change to tracked fieldsv324-v341
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: When people have a stroke, they often have difficulty moving their arms and hands. Transcranial magnetic stimulation (TMS) can improve how well people with and without stroke can move their arms and hands. But the effects of TMS are minor, and it doesn t work for everyone. Researchers want to study how to time brain stimulation so that the effects are more consistent. Objective: To understand how the brain responds to transcranial magnetic stimulation so that treatments for people with stroke can be improved. Eligibility: Adults ages 18 and older who had a stroke at least 6 months ago Healthy volunteers ages 50 and older Design: Participants will have up to 5 visits. At visit 1, participants will be screened with medical history and physical exam. Participants with stroke will also have TMS and surface electromyography (sEMG). For TMS, a brief electrical current will pass through a wire coil on the scalp. Participants may hear a click and feel a pull. Muscles may twitch. Participants may be asked to do simple movements during TMS. For sEMG, small electrodes will be attached to the skin and muscle activity will be recorded. At visit 2, participants will have magnetic resonance imaging (MRI). They will lie on a table that slides into a metal cylinder in a strong magnetic field. They will get earplugs for the loud noise. At visit 3, participants will have TMS, sEMG, and electroencephalography (EEG). For EEG, small electrodes on the scalp will record brainwaves. Participants will sit still, watch a movie, or do TMS. Participants may be asked to have 2 extra visits to redo procedures.
Trial Details
NCT Number NCT03288220
Lead Sponsor National Institute of Neurological Disorders and Stroke (NINDS)
Conditions Healthy, Stroke, Normal Physiology, Aging
Enrollment 114 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov